Editorial
 THE US SHOCKER   
 Wednesday, May 22, 2019 
 The action of 40 states of the US in filing a lawsuit accusing 20 top pharmaceutical companies including 7 Indian companies for conspiring to inflate prices of 100 commonly used medicines last week is not totally unexpected. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Researchers develop novel technique that reduces obstruction risk in heart valve replacement
17:00  [IST]Respivant Sciences begins patient dosing in phase 2b trial of RVT-1601 to treat persistent cough due to idiopathic pulmonary fibrosis
16:30  [IST]Lupin introduces generic Pulmicort Respules inhalation suspension in US market
16:00  [IST]WuXi Biologics signs letter of intent for long-term vaccine manufacturing contract
15:30  [IST]Allergy Therapeutics reports positive results from phase I study of Acarovac MPL in patients with HDM-induced allergic rhinoconjunctivitis
15:00  [IST]Insmed announces positive results from phase 3 CONVERT study of Arikayce in patients with refractory MAC lung disease
more news >>
TOP NEWS
08:00  [IST]Maha FDA urges state govt to include provision of sale licence for ayurvedic drugs in D&C Act to control spurious medicines
08:00  [IST]ICMR soon to begin phase III trial to evaluate efficacy and safety of two TB vaccines
08:00  [IST]Maharashtra FDA refers blood overcharging cases to state govt for final resolution
08:00  [IST]Technologies like 3D printing & AM hold the key to future in Indian healthcare: D J Sampathi of Intech DMLS
08:00  [IST]Renowned scientist Dr Mohan D Nair gets Dr Parvinder Singh Memorial Award
08:00  [IST]Pharma cos gear up to outsource FM services to address market needs & stricter global regulations
more news >>
YESTERDAY'S NEWS
18:00  [IST]Bridge Biotherapeutics presents positive data from phase I study of BBT-877 to treat idiopathic pulmonary fibrosis at ATS 2019 conference
17:00  [IST]Bayer, Nutreco ink R&D pact to develop new technologies & applications for animal health and nutrition industries
16:00  [IST]PTC Therapeutics announces winners of its PRIORITY programme to support research projects in rare, genetic disorders
15:00  [IST]Dale Medical launches new Hold-n-Place Catheter Securement devices
14:10  [IST]Torrent Pharma net loss at Rs.152 crore in Q4, dividend of 80%
14:00  [IST]T3D Therapeutics' PIONEER study of T3D-959 to treat Alzheimer's disease receives NIH grants
more news >>
INTERVIEW  
Advanced flooring, integral part of pharma & healthcare infrastructure
Agradeep Mondal, Director Sales, Interface South Asia115398Agradeep
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
CP: HI_Korea_2019_150x60
IPJ_2019_pharmabiz_150x60
Ipe_2019_150x 60
CPhI_Korea_2019_150x60
PharmaLytica150x60_2019
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |